Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel

Paul R Hunter, Julii Brainard
doi: https://doi.org/10.1101/2021.02.01.21250957

Article usage

Article usage: February 2021 to May 2025

AbstractFullPdf
Feb 20217469418398003
Mar 20211852817062995
Apr 202167806861719
May 202144537041351
Jun 20213954719805
Jul 20213333247712
Aug 2021283894556
Sep 20211689100578
Oct 20211236125378
Nov 2021897145273
Dec 2021877315634
Jan 2022767104311
Feb 20225851268165
Mar 202246560126
Apr 2022405115127
May 20223724695
Jun 202223926177
Jul 202230334189
Aug 202223855139
Sep 20222453797
Oct 202220246118
Nov 20221822542
Dec 20221381828
Jan 20231393539
Feb 20231152045
Mar 20231371743
Apr 20231231837
May 20231171435
Jun 20231421331
Jul 20231601234
Aug 20231431436
Sep 20232071734
Oct 20232001240
Nov 20231602131
Dec 20231091124
Jan 2024128538
Feb 20241281550
Mar 20241462172
Apr 20241762289
May 20241692439
Jun 20241622434
Jul 20241421146
Aug 20241851242
Sep 2024172937
Oct 20241901244
Nov 20241181238
Dec 2024852129
Jan 20251233429
Feb 20251544227
Mar 20251313045
Apr 20251684136
May 2025861737
Back to top
Posted February 03, 2021.
Download PDF
Data/Code
Email
Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel
Paul R Hunter, Julii Brainard
medRxiv 2021.02.01.21250957; doi: https://doi.org/10.1101/2021.02.01.21250957
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area